The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis

Abstract

Proton pump inhibitors increase the risk of infection in cirrhosis and should not be prescribed in these patients without specific indications. In contrast, the use of BBs is associated with a lower rate of infection and attenuates the consequences of infections in cirrhotic patients.